SPONSOR
Federal University of Health Science of Porto Alegre
Total Trials
2
Recruiting
2
Phases
Phase 3
Conditions studied: MeningitisEncephalitic InfectionEncephalitisMeningitis, FungalMeningitis, ViralMeningitis, BacterialDisseminated Histoplasma Capsulatum InfectionAIDS and InfectionsImmunosuppressionFungal Infection
Federal University of Health Science of Porto Alegre is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Meningitis, Encephalitic Infection, Encephalitis, Meningitis, Fungal.
The trial portfolio spans Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Federal University of Health Science of Porto Alegre
How many clinical trials has Federal University of Health Science of Porto Alegre sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Federal University of Health Science of Porto Alegre, of which 2 are actively recruiting participants. These trials cover conditions including Meningitis, Encephalitic Infection, Encephalitis. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Federal University of Health Science of Porto Alegre research focus on?
Federal University of Health Science of Porto Alegre clinical trials span Meningitis, Encephalitic Infection, Encephalitis, Meningitis, Fungal, Meningitis, Viral, and additional conditions. The research pipeline includes Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Federal University of Health Science of Porto Alegre clinical trial?
To participate in a Federal University of Health Science of Porto Alegre trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Federal University of Health Science of Porto Alegre trials with current recruitment status updated daily.
Clinical Trials by Federal University of Health Science of Porto Alegre
NCT07432113
Recruiting
Prediction of Infectious Agents in the Biofire® FilmArray bioMérieux Meningitis/Encephalitis Panel Based on Clinical Syndrome and Cerebrospinal Fluid Parameters: a Diagnostic Stewardship Proposal.
Meningitis
NCT05814432 Phase 3
Recruiting
Efficacy and Safety of High-dose Liposomal Amphotericin B for Disseminated Histoplasmosis in AIDS
Disseminated Histoplasma Capsulatum Infection
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology